Machine Learning Prediction of BRCA1/2 Variants in Ovarian Cancer

This research article assesses the performance of machine learning (ML) algorithms in predicting the presence of germline BRCA1/2 pathogenic variants in patients diagnosed with ovarian cancer (OC). The study analyzes clinical-pathological features from a cohort of 648 OC patients who underwent BRCA1/2 testing. Three supervised ML algorithms—random forest, boosting, and support vector machine—were employed to evaluate their effectiveness in predicting BRCA1/2 status. The results indicate that boosting was the most effective algorithm, achieving an accuracy of 84.5% in the test sample. The study also highlights the relative influence of various clinical features, such as family history of OC and personal history of breast cancer, on the predictive capabilities of the algorithms. While the findings suggest a promising role for ML in predicting BRCA1/2 status, the authors note that the accuracy and precision of these models remain suboptimal for clinical application, indicating a need for further research and validation.